摘要
International Journal of DermatologyEarly View Letter to the Editor Treatment of refractory hand eczema by dupilumab: A case report Hanyue Dong, Hanyue Dong Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaSearch for more papers by this authorWei Chen, Wei Chen Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaSearch for more papers by this authorBo Liang, Corresponding Author Bo Liang [email protected] Department of Dermatology and Venereology, The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, ChinaSearch for more papers by this authorHongmin Li, Corresponding Author Hongmin Li [email protected] orcid.org/0009-0005-9714-547X Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaSearch for more papers by this author Hanyue Dong, Hanyue Dong Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaSearch for more papers by this authorWei Chen, Wei Chen Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaSearch for more papers by this authorBo Liang, Corresponding Author Bo Liang [email protected] Department of Dermatology and Venereology, The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, ChinaSearch for more papers by this authorHongmin Li, Corresponding Author Hongmin Li [email protected] orcid.org/0009-0005-9714-547X Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaSearch for more papers by this author First published: 25 February 2024 https://doi.org/10.1111/ijd.17098 Conflict of interest: None. Funding source: This work was supported by funding from Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China (grant no. AYPYS2021-4), and Jiangsu Province Hospital of Chinese Medicine Foundation (grant no. y2021rc32). Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Coenraads PJ. Hand eczema. N Engl J Med. 2012; 367(19): 1829–1837. 10.1056/NEJMcp1104084 CASPubMedWeb of Science®Google Scholar 2Voorberg AN, Kamphuis E, Christoffers WA, Schuttelaar MLA. Efficacy and safety of dupilumab in patients with severe chronic hand eczema with inadequate response or intolerance to alitretinoin: a randomized, double-blind, placebo-controlled phase IIb proof-of-concept study. Br J Dermatol. 2023; 189(4): 400–409. https://doi.org/10.1093/bjd/ljad156 10.1093/bjd/ljad156 PubMedGoogle Scholar 3Loman L, Diercks GFH, Schuttelaar MLA. Three cases of non-atopic hyperkeratotic hand eczema treated with dupilumab. Contact Dermatitis. 2021; 84(2): 124–127. https://doi.org/10.1111/cod.13693 10.1111/cod.13693 CASPubMedWeb of Science®Google Scholar 4Halling AS, Zachariae C, Thyssen JP. Severe treatment-resistant acute and recurrent vesicular chronic hand eczema successfully treated with dupilumab. Contact Dermatitis. 2020; 83(1): 37–38. https://doi.org/10.1111/cod.13501 10.1111/cod.13501 PubMedWeb of Science®Google Scholar 5Oosterhaven JAF, Voorberg AN, Romeijn GLE, de Bruin-Weller MS, Schuttelaar MLA. Effect of dupilumab on hand eczema in patients with atopic dermatitis: an observational study. J Dermatol. 2019; 46(8): 680–685. https://doi.org/10.1111/1346-8138.14982 10.1111/1346-8138.14982 CASPubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation